lobbying_activities: 2635083

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2635083	eabbdcc0-290a-4ebf-a1fb-5cdfd54f9bbb	Q2	TAUZIN CONSULTANTS, LLC	400671007	SCILEX HOLDING COMPANY	2021	second_quarter	MMM	Issues related to fair competition, the generic drug market, drug costs, pain management, non-opioid alternatives, and prior authorization. Also issues related to COVID-19.	Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE			0	0	2021-07-12T10:50:31.850000-04:00